AzTrials
AzTrials

Burnout SyndromeNCT03535493

The Effect of ACT and Float REST on Burnout Syndrome.

A study testing Acceptance and Commitment Therapy (ACT), Float REST and ACT + Float REST in people with Burnout Syndrome, run by Amrinder Babbra at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

In 1982, Steven Hayes, a clinical psychologist, developed Acceptance and Commitment Therapy (ACT), a unique empirically based psychological intervention that uses acceptance and mindfulness strategies, together with commitment and behavior change strategies, to increase psychological flexibility. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Burnout Syndrome
What is being tested?
Acceptance and Commitment Therapy (ACT), Float REST and ACT + Float REST
Could I receive a placebo?
No, everyone receives an active treatment
How many people
45 participants
Where
1 siteUnited States
Study dates
1 Jun 2018to 27 Aug 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Trial locations and contacts

1 site in 1 country.

United States1 site
  • International Behavioral Research Institute

    Saint Charles, Illinois, 60174

Other trials in United States

About this study

Official title: The Effect of Acceptance and Commitment Therapy (ACT) and Float REST (Restricted Environmental Stimulation Therapy) on Burnout Syndrome.

In 1982, Steven Hayes, a clinical psychologist, developed Acceptance and Commitment Therapy (ACT), a unique empirically based psychological intervention that uses acceptance and mindfulness strategies, together with commitment and behavior change strategies, to increase psychological flexibility. In 1954, John Lilly, a cognitive neuroscientist, developed the sensory deprivation tank (known today as Floatation Restricted Environmental Stimulation Therapy - Float REST), to access a wide range of healing, higher brain functions, and meditation through an unparalleled deep relaxation state. In this study, the investigators aim to examine whether participants in the ACT + Float REST condition will have larger decreases of the burnout phenomenon than those who receive either only ACT or Float REST.

Being tested
Acceptance and Commitment Therapy (ACT), Float REST, ACT + Float REST
Medical subject headings
Burnout, Psychological

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Acceptance and Commitment Therapy (ACT)Behavioural

    An ACT session entails a mindfulness-based training to foster and nurture effective behavioral and emotional responding to distress.

  • Float RESTBehavioural

    Also called Float Therapy, Isolation Tank, Sensory Deprivation Tank

    A float session entails laying supine in a light-proof, sound-proof tank consisting of a shallow pool of water (approximately 10 inches set to approximately 94.5 degrees to match skin temperature) with a high concentration of Epsom salt (approximately 1200 pounds) for 60 minutes.

  • ACT + Float RESTBehavioural

    The combined intervention will combine ACT and Float REST. An ACT session entails a mindfulness-based training to foster and nurture effective behavioral and emotional responding to distress. A float session entails laying supine in a light-proof, sound-proof tank consisting of a shallow pool of water (approximately 10 inches set to approximately 94.5 degrees to match skin temperature) with a high concentration of Epsom salt (approximately 1200 pounds) for 60 minutes.

Study groups in NCT03535493
Study groupRoleWhat they receive
Acceptance and Commitment Therapy (ACT)Active comparatorNot described
Receives: Behavioral: Acceptance and Commitment Therapy (ACT)
Float RESTActive comparatorNot described
Receives: Behavioral: Float REST
ACT + Float RESTExperimentalNot described
Receives: Behavioral: ACT + Float REST

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Assessing Change in Maslach Burnout Inventory - Human Services Survey (MBI-HSS)

    A 22 item scale that measures depersonalization, emotional exhaustion, and personal accomplishment. It is designed for professionals in human services in an array of occupations including nurses, physicians, health aides, social workers, health counselors, therapists, police, correctional officers, clergy, and other fields focused on helping people live better lives by offering guidance, preventing harm, and ameliorating cognitive, emotional, or physical problems.

    Measured: Metric will be used as screening prior to study intervention; continuous measurement at week 2, week 4, week 6, week 8 and at one month follow-up.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 May 2018
  2. Study start1 Jun 2018
  3. Primary completion27 Aug 2018
  4. Study completion27 Aug 2018

Why it stopped: Ethics Committee concerns.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
45 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03535493
Sponsor's protocol ID
IBRI
Status last verified
Aug 2018
First submitted
13 May 2018
Last updated
29 Aug 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Acceptance and Commitment Therapy (ACT), Float REST and ACT + Float REST in people with Burnout Syndrome, run by Amrinder Babbra at 1 site in United States.

The full registered description is in the About this study section and the official record.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 29 Aug 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Ethics Committee concerns.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Assessing Change in Maslach Burnout Inventory - Human Services Survey (MBI-HSS) (time frame: Metric will be used as screening prior to study intervention; continuous measurement at week 2, week 4, week 6, week 8 and at one month follow-up.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Aug 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in